Skip to content
ONTARIO SECURITIES COMMISSION APPROVES AVICANNA’S APPLICATION FOR MANAGEMENT CEASE TRADE ORDER
About
About
People
Investors
Investor Relations
News and Press
Portfolio
Pharmaceutical Pipeline
Aureus Santa Marta
Rho Phyto
Education
Avicenna Academy
Symposium
MyMedi.ca
Contact
About
About
People
Investors
Investor Relations
News and Press
Portfolio
Pharmaceutical Pipeline
Aureus Santa Marta
Rho Phyto
Education
Avicenna Academy
Symposium
MyMedi.ca
Contact
Instagram
Twitter
Linkedin
Linkedin
Twitter
Instagram
About
About
People
Investors
Investor Relations
News and Press
Portfolio
Pharmaceutical Pipeline
Aureus Santa Marta
Rho Phyto
Education
Avicenna Academy
Symposium
MyMedi.ca
Contact
×
About
About
People
Investors
Investor Relations
News and Press
Portfolio
Pharmaceutical Pipeline
Aureus Santa Marta
Rho Phyto
Education
Avicenna Academy
Symposium
MyMedi.ca
Contact
News & Press
Avicanna Announces Changes to its Board of Directors
23 December 2025
Avicanna Applauds President Trump’s Executive Order to Reclassify Cannabis & Provides Scientific Update
19 December 2025
Avicanna Announces Pre-Clinical Data Supporting Enhanced Absorption and Patent Filing for Novel Oral Delivery Platform
19 November 2025
Avicanna Reports Q3 2025
14 November 2025
Avicanna Announces Change in CFO
12 September 2025
Avicanna Subsidiary Completes Export of CBD Dominant Cannabis Flower into Switzerland
3 September 2025
« Prev
1
2
3
4
5
6
7
Next »